Our investment case STRONG GLOBAL PORTFOLIO ACROSS DIVERSE MARKETS We have a broad global product portfolio, with over 700 products in approximately 2,200 dosage forms and strengths, across multiple therapeutic categories.
This is a competitive advantage, creating a leading presence in key markets and strategically positioning us to capture opportunities in a dynamic market environment.
Good momentum in new product launches, with an increasing focus on more differentiated and complex products, is enabling us to meet patient demand for a wider range of high-quality, affordable medicines.
Products on the market 707 707 588 582 14 15 16 Hikma Pharmaceuticals PLC 8 Strategic report Corporate governance Financial statements Annual Report 2016 9
